Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast [NA]
An interventional clinical trial evaluated whether postoperative radiation therapy after surgery improves outcomes for women with phyllodes …
-
CLINICAL_TRIALS other · 2019-01-22Clinical Trial Update: The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial [Phase 2]
This document provides an update on the plasmaMATCH Phase 2 trial in advanced breast cancer, evaluating plasma-based molecular profiling to …
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of PEG-rhG-CSF in breast cancer patients receiving intensive chemotherapy.
-
FDA approval · 2019-01-18FDA Approved: CYCLOPHOSPHAMIDE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for a generic cyclophosphamide product. This marks approval of a generic formulation …
-
CLINICAL_TRIALS research · 2019-01-18Clinical Trial Update: Added Value of Contrast Enhanced Spectral Mammography, CESM. A Pilot Study. [NA]
This document reports a completed pilot study evaluating the added value of Contrast Enhanced Spectral Mammography (CESM) for breast cancer.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor [Phase 1, Phase 2]
Clinical trial update on Vivomixx for preventing bone loss in women with breast cancer treated with aromatase inhibitors (Phase 1/2), with s…
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer [Phase 1]
This document reports a completed Phase I clinical trial from The Netherlands Cancer Institute evaluating carboplatin-olaparib in combinatio…
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Topical Doxepin for Radiation-induced Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of topical doxepin to treat radiation-induced dermatitis in breast cancer patien…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Preoperative Herceptin and Navelbine for Breast Cancer [Phase 2]
Phase 2 trial update evaluating preoperative Herceptin (trastuzumab) and Navelbine (vinorelbine) for breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells [Phase 1, Phase 2]
Clinical trial update for an activated primary natural killer cell therapy showing intent to assess anti-tumor effects in multiple cancers i…
-
FDA approval · 2019-01-11FDA Approved: LETROZOLE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for a generic version of letrozole.
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer [Phase 4]
Phase 4 clinical trial update evaluating albumin-bound paclitaxel with carboplatin as neoadjuvant chemotherapy for luminal B/HER-2 negative …
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: Using Bupivacaine Locally in the Mastectomy Drains to Control Postoperative Pain [Phase 4]
Phase 4 trial investigating local bupivacaine use in mastectomy drains to manage postoperative pain in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer [Phase 4]
Phase 4 clinical trial update on sentinel lymph node biopsy findings in patients with breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi [Phase 3]
A Phase III trial evaluating buparlisib (BKM120) with fulvestrant in HR+,HER2-, AI-treated metastatic breast cancer that progressed after mT…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel Compared With Trastuzumab + Placebo + Docetaxel [Phase 3]
Phase 3 trial comparing trastuzumab plus pertuzumab and docetaxel versus trastuzumab with placebo and docetaxel in early-stage or locally ad…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Fulvestrant With or Without Ganetespib in HR+ Breast Cancer [Phase 2]
Phase 2 study assessing fulvestrant with or without ganetespib in HR-positive breast cancer has completed, with results posted in January 20…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating ibritinib in combination with MEDI4736 in relapsed/refractory solid tumors completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: 18F-FSPG PET/CT for Cancer Patients on Therapy [Phase 2]
Phase 2 clinical trial update on 18F-FSPG PET/CT for cancer patients undergoing therapy; study status completed with results posted.
-
CLINICAL_TRIALS research · 2019-01-03Clinical Trial Update: Circadian Thermal Sensing to Detect Breast Disease [Phase 1, Phase 2]
Clinical trial update on circadian thermal sensing for detecting breast disease, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS withdrawal · 2018-12-27Clinical Trial Update: Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer [Phase 4]
A Phase 4 clinical trial evaluating endocrine therapy for HER2-negative, low-risk invasive breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Safety Study of the Hypo-fractionated (Large Doses) Radiation Therapy in Post-menopausal Women With Breast Cancers [Phase 1, Phase 2]
A completed Phase 1/2 safety study evaluating hypo-fractionated high-dose radiation therapy in post-menopausal women with breast cancer.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating everolimus in combination with trastuzumab and paclitaxel for HER2-positive locally advanced or metastatic breast c…
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Phase II Trial for Large ER-Negative Breast Cancers [Phase 2]
Phase II trial update for large ER-negative breast cancers; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer. [NA]
Completed presurgical (neoadjuvant) trial of letrozole in early-stage breast cancer; results were posted in 2018.